These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15142889)

  • 1. Carcinogenicity of aminophenylnorharman, a possible novel endogenous mutagen, formed from norharman and aniline, in F344 rats.
    Kawamori T; Totsuka Y; Uchiya N; Kitamura T; Shibata H; Sugimura T; Wakabayashi K
    Carcinogenesis; 2004 Oct; 25(10):1967-72. PubMed ID: 15142889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent genotoxicity of aminophenylnorharman, formed from non-mutagenic norharman and aniline, in the liver of gpt delta transgenic mouse.
    Masumura K; Totsuka Y; Wakabayashi K; Nohmi T
    Carcinogenesis; 2003 Dec; 24(12):1985-93. PubMed ID: 12970073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological significance of aminophenyl-β-carboline derivatives formed from co-mutagenic action of β-carbolines and aniline and o-toluidine and its effect on tumorigenesis in humans: A review.
    Totsuka Y; Wakabayashi K
    Mutat Res Genet Toxicol Environ Mutagen; 2020; 850-851():503148. PubMed ID: 32247557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-initiating potency of a novel heterocyclic amine, aminophenylnorharman in mouse colonic carcinogenesis model.
    Kohno H; Totsuka Y; Yasui Y; Suzuki R; Sugie S; Wakabayashi K; Tanaka T
    Int J Cancer; 2007 Oct; 121(8):1659-64. PubMed ID: 17557291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of DNA adduct formed with aminophenylnorharman, being responsible for the comutagenic action of norharman with aniline.
    Totsuka Y; Takamura-Enya T; Kawahara N; Nishigaki R; Sugimura T; Wakabayashi K
    Chem Res Toxicol; 2002 Oct; 15(10):1288-94. PubMed ID: 12387627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagens formed from beta-carbolines with aromatic amines.
    Totsuka Y; Takamura-Enya T; Nishigaki R; Sugimura T; Wakabayashi K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Mar; 802(1):135-41. PubMed ID: 15036005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testicular toxicity in F344 rats by aminophenylnorharman, formed from norharman and aniline.
    Totsuka Y; Kawamori T; Hisada S; Mitsumori K; Ishihara J; Sugimura T; Wakabayashi K
    Toxicol Appl Pharmacol; 2001 Sep; 175(2):169-75. PubMed ID: 11543649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of cytochrome P-450s involved in the formation of APNH from norharman with aniline.
    Nishigaki R; Totsuka Y; Takamura-Enya T; Sugimura T; Wakabayashi K
    Mutat Res; 2004 Aug; 562(1-2):19-25. PubMed ID: 15279827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal and developmental toxicity in mice by aminophenylnorharman, formed from norharman and aniline.
    Naga T; Yoshimura S; Totsuka Y; Wakabayashi K
    Hum Exp Toxicol; 2002 Mar; 21(3):147-51. PubMed ID: 12102540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo formation of aminophenylnorharman from norharman and aniline.
    Totsuka Y; Kataoka H; Takamura-Enya T; Sugimura T; Wakabayashi K
    Mutat Res; 2002 Sep; 506-507():49-54. PubMed ID: 12351144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of aminophenylnorharman, a possible endogenous mutagenic and carcinogenic compound, in human urine samples.
    Nishigaki R; Totsuka Y; Kataoka H; Ushiyama H; Goto S; Akasu T; Watanabe T; Sugimura T; Wakabayashi K
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):151-6. PubMed ID: 17220344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative DNA damage by an N-hydroxy metabolite of the mutagenic compound formed from norharman and aniline.
    Ohnishi S; Murata M; Oikawa S; Totsuka Y; Takamura T; Wakabayashi K; Kawanishi S
    Mutat Res; 2001 Jul; 494(1-2):63-72. PubMed ID: 11423346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of sister chromatid exchanges and chromosome aberrations in cultured mammalian cells treated with aminophenylnorharman formed by norharman with aniline.
    Ohe T; Takata T; Maeda Y; Totsuka Y; Hada N; Matsuoka A; Tanaka N; Wakabayashi K
    Mutat Res; 2002 Mar; 515(1-2):181-8. PubMed ID: 11909766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of an RNA adduct formed from aminophenylnorharman.
    Nishimura K; Totsuka Y; Higuchi T; Kawahara N; Sugimura T; Wakabayashi K
    Nucleic Acids Symp Ser (Oxf); 2009; (53):211-2. PubMed ID: 19749335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of liver preneoplastic lesions by aminophenylnorharman, formed from norharman and aniline, in male F344 rats.
    Kawamori T; Totsuka Y; Ishihara J; Uchiya N; Sugimura T; Wakabayashi K
    Cancer Lett; 2001 Feb; 163(2):157-61. PubMed ID: 11165749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural determination of a mutagenic aminophenylnorharman produced by the co-mutagen norharman with aniline.
    Totsuka Y; Hada N; Matsumoto K; Kawahara N; Murakami Y; Yokoyama Y; Sugimura T; Wakabayashi K
    Carcinogenesis; 1998 Nov; 19(11):1995-2000. PubMed ID: 9855015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of aminophenylnorharman, aminomethylphenylnorharman and aminophenylharman to genotoxic metabolites by human N-acetyltransferases and cytochrome P450 enzymes expressed in Salmonella typhimurium umu tester strains.
    Oda Y; Totsuka Y; Wakabayashi K; Guengerich FP; Shimada T
    Mutagenesis; 2006 Nov; 21(6):411-6. PubMed ID: 17067997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of elevated liver carcinogenicity of aminophenylnorharman in p53-deficient mice.
    Iidaka T; Tsukamoto T; Totsuka Y; Hirata A; Sakai H; Shirai N; Yamamoto M; Wakabayashi K; Yanai T; Masegi T; Donehower LA; Tatematsu M
    Cancer Lett; 2005 Jan; 217(2):149-59. PubMed ID: 15617832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational analysis of Ctnnb1 and Apc in tumors from rats given 1,2-dimethylhydrazine or 2-amino-3-methylimidazo[4,5-f]quinoline: mutational 'hotspots' and the relative expression of beta-catenin and c-jun.
    Blum CA; Tanaka T; Zhong X; Li Q; Dashwood WM; Pereira C; Xu M; Dashwood RH
    Mol Carcinog; 2003 Apr; 36(4):195-203. PubMed ID: 12669311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. γ-H2AX formation in the urinary bladder of rats treated with two norharman derivatives obtained from o-toluidine and aniline.
    Toyoda T; Totsuka Y; Matsushita K; Morikawa T; Miyoshi N; Wakabayashi K; Ogawa K
    J Appl Toxicol; 2018 Apr; 38(4):537-543. PubMed ID: 29143974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.